Wolfgang H. Fischer

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue.

J. Becker, E. Bröcker, W. Fischer, 2001, Immunity.

A Role for CD81 in Early T Cell Development

W. Havran, Maria E. Rhein, R. Boismenu, 1996, Science.

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

J. Koch, R. Başar, K. Rezvani, 2021, Clinical Cancer Research.

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors

J. Koch, S. Wingert, M. Tesar, 2021, mAbs.

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin

E. Oldfield, I. Verma, Xiaoying Zhou, 2014, Science Translational Medicine.